Open access · CC-BY
via OpenAlex
From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapy
Jason M. Brenchley, Sergio Serrano Villar
Microbiome · 2024 · ▲ 22 citations
Abstract
BACKGROUND: Although the microbiota has been extensively associated with HIV pathogenesis, the majority of studies, particularly those using omics techniques, are largely correlative and serve primarily as a basis for hypothesis generation. Furthermore, most have focused on characterizing the taxonomic composition of the bacterial component, often overlooking other levels of the microbiome. The intricate mechanisms by which the microbiota influences immune responses to HIV are still poorly understood. Interventional studies on gut microbiota provide a powerful tool to test the hypothesis of whether we can harness the microbiota to improve health outcomes in people with HIV. RESULTS: Here, we review the multifaceted role of the gut microbiome in HIV/SIV disease progression and its potential as a therapeutic target. We explore the complex interplay between gut microbial dysbiosis and systemic inflammation, highlighting the potential for microbiome-based therapeutics to open new avenues in HIV management. These include exploring the efficacy of probiotics, prebiotics, fecal microbiota transplantation, and targeted dietary modifications. We also address the challenges inherent in this research area, such as the difficulty in inducing long-lasting microbiome alterations and the complexities of study designs, including variations in probiotic strains, donor selection for FMT, antibiotic conditioning regimens, and the hurdles in translating findings into clinical practice. Finally, we speculate on future directions for this rapidly evolving field, emphasizing the need for a more granular understanding of microbiome-immune interactions, the development of personalized microbiome-based therapies, and the application of novel technologies to identify potential therapeutic agents. CONCLUSIONS: Our review underscores the importance of the gut microbiome in HIV/SIV disease and its potential as a target for innovative therapeutic strategies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s40168-024-01825-w
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Brenchley, J.M., & Villar, S.S. (2024). From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapy. <em>Microbiome</em>. https://doi.org/10.1186/s40168-024-01825-w
Vancouver
Brenchley JM, Villar SS. From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapy. Microbiome. 2024. doi:10.1186/s40168-024-01825-w.
BibTeX
@article{jason2024Fromdy,
title = {From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapy},
author = {Jason M. Brenchley and Sergio Serrano Villar},
journal = {Microbiome},
year = {2024},
doi = {10.1186/s40168-024-01825-w},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Emerging Trends in Metabolites 2024
Open access · CC-BY
Gut Microbiome Dysbiosis During Metabolic Disorders: Diabetes
Journal of Clinical Medicine 2024
Open access · CC-BY
The Gut Microbiome in Sepsis: From Dysbiosis to Personalized Therapy
Yearbook of pediatric endocrinology 2025
Open access · CC-BY
Exploring the Role of the Gut Microbiome Across the Lifespan: Implications for Aging and Metabolic Disorders
Frontiers in Immunology 2021
Open access · CC-BY
Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body
Frontiers in Medicine 2022
Open access · CC-BY
Gut Dysbiosis and Kidney Diseases
Journal of Cachexia Sarcopenia and Muscle 2021
Open access · CC-BY